28.8 F
New York
Saturday, January 23, 2021
Home Healthcare

Healthcare

Healthcare company and market news.

On Sunday, President Trump announced that the Food and Drug Administration (FDA) has approved the use of convalescent plasma in COVID-19 patients. The FDA approved the plasma product as an emergency use for novel coronavirus patients. The president called the news a “historic breakthrough”...
The FDA has approved a heart pump to treat COVID-19 patients who have severe heart and lung failure. The approval was an emergency measure to use the Impella heart pump made by Abiomed. The heart pump works with an oxygen machine to treat coronavirus patients with specific...
Eastman Kodak stock skyrocketed this week after President Trump announced a deal to have the historical photography company make generic ingredients. Shares for Kodak were up by over 2700 percent at one point this week on the news. The NYSE halted trading several times due to the...
According to researchers at the University of Michigan, an immune suppressant drug called tocilizumab may help treat COVID-19 related cytokine storm. The medication, generally prescribed to rheumatoid arthritis patients, was found to reduce mortality in some severely ill coronavirus patients.  The sickest COVID-19 patients...
Gilead Sciences, the drugmaker for remdesivir, the promising new coronavirus treatment, has announced that it will begin charging for the drug in July. The pharmaceutical company had been donating some of the medication for government distribution since May when it received emergency authorization use.
On Friday, the Food and Drug Administration gave emergency approval for the emergency treatment of the COVID-19 coronavirus with the use of remdesivir. The drug has been trialed as an experimental treatment in patients with the virus. The federal trial of the antiviral medication showed that remdesivir,...
As good news from Gilead Sciences about a possible coronavirus treatment hit the airways, stocks may end their best month in many decades. The S&P 500, in particular, is on track for its best performance since 1974. This, in spite, of sharp declines in economic activity within...
Shares of Gilead Sciences were up by more than 16 percent after-hours on Thursday once news of a promising drug trial broke. The drug, Remdesivir, is showing positive results in treating the novel coronavirus known as COVID-19. The drug trial is in phase 3...
Thirty volunteers from the nation’s largest tech companies built a coronavirus tracking site in six days. The volunteers from Apple, Amazon, Alphabet Google and others worked six straight nights to make it happen.  The team of volunteers worked closely with epidemiologists, including John Brownstein,...
Just as the coronavirus makes its way around the world, the U.S. reported its first death from the virus. A man in his 50s from Seattle, Washington who had chronic health issues was the first casualty of the disease. Meanwhile, a cluster outbreak was also reported in...